Robert I. Cano

Gastroenterology

6169 N Thesta St
Fresno, CA 93710

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophy.

Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophy.

Journal: Molecular therapy. Advances

Published: August 01, 2025

Showing 1-1 of 1

Last Updated: 09/26/2026